A Phase III, Multi-center, Open-label Trial to Investigate the Impact of a Treat, Counsel and Cure Strategy in Men Who Have Sex With Men With Hepatitis C Infection in the Swiss HIV Cohort Study
Latest Information Update: 14 Apr 2022
Price :
$35 *
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 Apr 2022 Results assessing long-term effect of this hepatitis C micro-elimination program published in the Clinical Infectious Diseases
- 30 Oct 2021 Results presented at the 18th European AIDS Conference
- 13 Aug 2018 Results (n=122) published in the Clinical Infectious Diseases.